23.4 C
New York
Monday, June 15, 2026

Tag: call

Meritage Homes Second Quarter 2026 Earnings Conference Call and Webcast Scheduled for July 30, 2026

SCOTTSDALE, Ariz., June 11, 2026 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH), the fifth largest public homebuilder in the U.S., plans to release the Company's second quarter 2026 results on Wednesday, July 29, 2026 after the market closes. Management will host a conference call to discuss the results at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) on Thursday, July 30, 2026.

Precipio to Present at the Planet MicroCap Las Vegas

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that it will be presenting at the Planet MicroCap Las Vegas 2026 on Wednesday, June 17, 2026, at 9:00 AM (Local Time, 12:00pm EST) at the Bellagio Resort & Hotel. Ilan Danieli, CEO and Zaki Sabet, COO of Precipio will be hosting the presentation and answering questions at the conclusion.

American Outdoor Brands Fourth Quarter and Full Year Fiscal 2026 Financial Results and Conference Call Alert

COLUMBIA, Mo., June 11, 2026 /PRNewswire/ -- American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an innovation company that provides product solutions for outdoor...

Federal Realty Investment Trust Announces Second Quarter 2026 Earnings Release Date and Conference Call Information

NORTH BETHESDA, Md., June 11, 2026 /PRNewswire/ -- Federal Realty Investment Trust (NYSE: FRT) will announce its second quarter 2026 earnings results before market...

ENSG Investor News: If You Have Suffered Losses in Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.

An InventHelp 123Invent Client Develop New Automatic Windshield Wiper System (CTK-1502)

PITTSBURGH, June 11, 2026 /PRNewswire/ -- "We thought there could be a more convenient way to activate the windshield wipers during rain," said one...

Purpose Receives Approval to Launch SpaceX (SPCX) Yield Shares ETF, Set to Launch on Monday, June 15, 2026

- Purpose Investments has filed, and been receipted for, an amendment to the Purpose Yield Shares prospectus qualifying Purpose SpaceX Yield Shares ETF.

VEG ER for Pets Partners with VetRec to Advance AI-Powered Documentation Across Emergency Veterinary Care

Following a six-month pilot, VetRec becomes VEG's official AI scribe partner, now live across more than 70% of VEG hospitals.WHITE PLAINS, N.Y., June 11,...

AVAV Shareholder Alert: AeroVironment, Inc. Securities Class Action Lawsuit – Investors Should Contact SueWallSt

Alert: Claims Focus on AeroVironment's Reliance on a Single-Vendor Bespoke Contract That Allegedly Left Investors Exposed When the Space Force Shifted to Multi-Vendor Commercial...

Dana Incorporated Announces Agreement to Combine with Eaton’s Mobility Business, Strengthens Dana’s Position as a Leading Global Powertrain Systems Provider

Creates a premier, global powertrain leader focused on commercial and light vehicles with approximately $11 billion in sales and approximately $1.7 billion adjusted EBITDA...

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

Patients in the IMAAVY 30 mg/kg treatment groupa achieved statistically significant durable hemoglobin responseb, with mean hemoglobin improvement of at least 1 g/dL as...

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results
and Provides Business Update

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the...

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 10, 2026 in the securities class action first filed by the Firm.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCall